View from the 32 floor of One Beacon Street, Boston, with the dome of the State House at the left and Charles River Basin and Cambridge further out.
— Robert Whitcomb
The most recent COVID-19 roundup from The New England Council (newenglandcouncil.com):
UMass Study Finds that Seniors are Often Excluded From COVID-19 Trials – A University of Massachusetts Medical School affiliated study has found that seniors, who are often the most at risk for COVID-19, are excluded by more than half of COVID-19 clinical trials. The study made recommendations for future trials, in including more patients in this demographic. Read more here.
Harvard Medical School and Mass General Publish Study on Protective Antibodies – Researchers at Harvard Medical School and Massachusetts General Hospital have found that protective antibodies in patients who survive serious COVID-19 infections may provide longer protection against the virus. The study offers further insight into how long antibodies may remain in the system and provides recommendations for further antibody testing. Read more here.
Beth Israel Medical Center Launches Clinical Trial for Antiviral COVID-19 Treatment – Beth Israel Deaconess Medical Center has launched a new study on antiviral treatment for patients at home with COVID-19. The TREAT-NOW study is being conducted in tandem with Vanderbilt University and the University of Colorado to see if a well-known antiviral drug can help prevent or mitigate serious COVID-19 symptoms. Read more here.
New Tool Developed at Mass General Helps Predict Outbreaks in Counties that Host Pro Football Games – Researchers at Massachusetts General Hospital have expanded the scope of their COVID-19 Outbreak Detection Tool to incorporate NFL and NCAA football games as potential super-spreader events.
©2020 The New England Council
